Table 1.
The overview of the emerging corona viruses.
SARS-CoV | MERS-CoV | SARS-CoV-2 | REF | ||
---|---|---|---|---|---|
1 | Epicentre | Guangdong Province (2002) | Arabian Peninsula (2012) | Global Pandemic | [5], [6], [7], [33] |
2 | Nomenclature | Betacoronavirus, subgenus Sarbecovirus | Betacoronavirus, subgenus Merbecovirus | Betacoronavirus, subgenus Sarbecovirus Beta-CoV lineage B | [3], [10], [11] |
3 | Reservoir | Bat, Palm civets | Bat, Camels | Bat, Snakes | [37], [38] |
4 | Population Affected | 8096 | >2000 | >4,000,000 | [5], [20], [26], [28], [29], [30], [33] |
5 | Incubation | 2–13 days | 2–14 days | 2–12 days | [5], [31] |
6 | Transmission | Animal to human, human to human | Animal to human, human to human | Animal to human, human to human | [5], [34] |
7 | Multi-systemic complications | YES | YES | YES | [34], [35], [37] |
8 | Neurological complications | YES | YES | YES | [15], [20], [21] |
ABBREVIATION: CoV-Corona Virus, REF-References |